University of Toronto professor Ian Tannock has received the prestigious ESMO award for his efforts helping to design trials identifying an ideal chemotherapy dosage for men with metastatic castration-resistant prostate cancer.
According to ESMO, the ESMO award "is conferred on a member who has made an outstanding contribution to the development of oncology worldwide and who recognizes the importance of promoting oncology as a specialty within the international community."
To read more about the ESMO award, including past recipients, click here.
No comments:
Post a Comment